Chapter 11 News: Molecular Insight Pharmaceuticals Plans to File

CAMBRIDGE, MA.- Molecular Insight Pharmaceuticals Inc. said Friday it is filing for Chapter 11 bankruptcy protection as part of an agreement with an investor that will buy 90 percent of its stock.  For more from Boston.com, click here

Leave a Reply

Your email address will not be published. Required fields are marked *